Blog & News

“What’s that smell cancer?” based on Canvax it is highlighted by the spanish press

Date: 2016-08-25 by Canvax
“What’s that smell cancer?” based on Canvax it is highlighted by the spanish press

This news, which has been highlighted by more than one hundred national newspapers, has been explained that a trained dog is able to detect whether a person has cancer sickness even before medical tests could determine it. So is how Canvax hast got olfactory proteins with the aim of being able to get a better […]

Learn More

Canvax Biotech, Villapharma Research S.L. and Proteros Biostructures Gmbh announce FRIDASTEM, a Eurostars awarded consortium for Drug Discovery and Development targeting Cancer Stem Cells.

Date: 2016-05-31 by Canvax
Canvax Biotech, Villapharma Research S.L. and Proteros Biostructures Gmbh  announce FRIDASTEM, a Eurostars awarded consortium for Drug Discovery and  Development targeting Cancer Stem Cells.

FRIDASTEM platform has been established with the aim to accelerate small molecule drug discovery against specific kinases and GPCRs involved in Cancer Stem Cells (CSC) proliferation, migration, invasion or metastasis. CSC are believed to be the cause of resistance to current cancer therapies. The drug discovery of drugs targeting this population of cells within a tumoris therefore of […]

Learn More

Elier Paz interviewed by Diario Córdoba

Date: 2015-11-10 by Canvax
Elier Paz interviewed by Diario Córdoba

In today´s edition, Diario Córdoba publishes an interview with Elier Paz, CEO of Canvax Biotech. During the interview, the journalist Irina Marzo asked about most updated information about the company, currents projects inside Drug discovery and lead molecules. For more information, read the full new here.

Learn More

Canvax has been awarded with a RETOS-COLABORACIÓN Program funded by MINECO

Date: 2015-11-3 by Canvax
Canvax has been awarded with a RETOS-COLABORACIÓN Program funded by MINECO

Canvax Biotech has recently received an endorsement from the Ministry of Economy and Competitiveness (MINECO) through the RETOS-COLABORACIÓN Program. Canvax Biotech will lead the consortium composed by Villapharma Research from Murcia, Instituto de Investigación Biomédica of Bellvitge (IDIBELL), two scientific groups from Instituto de Investigación Biomédica of Córdoba (IMIBIC) and two groups from Universidad de […]

Learn More

Canvax awarded with a Torres Quevedo contract

Date: 2015-10-26 by Canvax
Canvax awarded with a Torres Quevedo contract

Canvax has been recently reinforced its Drug Discovery program by the incorporation of PhD Emilio González González, who was awarded with a Torres Quevedo contract from MINECO (PTQ 2014). He is an experienced scientist-entrepreneur who received his PhD at Complutense University and Centro de Investigaciones Biológicas and received a postdoctoral/biotech education at Stanford University/Transderm and […]

Learn More

Canvax is awarded with phase I SME instrument H2020

Date: 2015-08-27 by Canvax
Canvax is awarded with phase I SME instrument H2020

Canvax Biotech’s odour-GPCR-based diagnostics technology is one of the few excellent projects awardees of the highly competitive H2020. For more information, read the attached pdf with all awardees here.  

Learn More

Canvax hosts the annual meeting of the SNC-Integra project

Date: 2015-07-10 by Canvax
Canvax hosts the annual meeting of the SNC-Integra project

Canvax Biotech has hosted in its headquarters the last Technical Committee of the SNC-Integra project, developed by a biotechnology cluster of Andalusian companies, led by Laboratorios Rovi and where, together with Canvax Biotech,there are participating companies such as VivaCell, Bionaturis, GMV, Vivia Allosterics and Vivia Biotech. This technical committee presented the main conclusions of this […]

Learn More

Canvax Biotech gets 'Invest in Spain' funds

Date: 2014-09-27 by Canvax
Canvax Biotech gets 'Invest in Spain' funds

Canvax Biotech has been a beneficiary of ‘Invest in Spain’ funds from ICEX, that aims to help these companies with foreign participation to develop R&D projects  in Spain. The project is based on FRIDA, a cell sensor developed by Canvax, for functional screening of the activity of compounds against the GPCRs to find news drugs […]

Learn More

Canvax participates in Cenit Oncológica project

Date: 2013-09-13 by Canvax
Canvax participates in Cenit Oncológica project

The Oncology Consortium, composed of seven Spanish biotech companies and led by PharmaMar, has generated since its launch four years ago, a total of 9 patent applications, 5 papers and 13 posters at international conferences, plus three doctoral theses and 12 scientific publications Together with Canvax and PharmaMar, the other companies involved in the consortium […]

Learn More